ISO 18362-2016 PDF

ISO 18362-2016 PDF

Manufacture of cell-based health care products - Control of microbial risks during processing

$13.00 $26.00 -50%
Product Code: ISO 18362
Stock In Stock
Edition: 1ST
Published: 02/01/2016
Number of Pages: 42
File Size: 1 file, 745 Bytes

Available Options

Product Description

Manufacture of cell-based health care products - Control of microbial risks during processing

Introduction: 0.1 General A cell-based health care product (CBHP) comprises prokaryotic or eukaryotic cells or cell derived biological entities as an essential ingredient. Cell-based or cell derived starting material used in the manufacture of a CBHP can be viable or non-viable and of human, animal, microbial or plant origin. A common feature of CBHPs is that their efficacy is based on their biological properties. They are classified as medicines, medical devices, biologics or combination products depending on the international, national and/or regional regulations that govern supply of these products. CBHPs might be limited in their ability to withstand sterilization and purification methods. This International Standard focuses on process rather than product. It describes the minimum elements necessary for a risk-based approach to the processing of a CBHP in order to reduce the potential for an increase in intrinsic contamination of product and to avoid extrinsic contamination of product. The design of the processes, equipment, facilities, utilities, the conditions of preparation and addition of buffers and reagents, and training of the operators are key considerations to minimize contamination. 0.2 CBHPs labelled as ‘sterile’ A CBHP that is labelled as ‘sterile’ is sterilized by a terminal sterilization process or is aseptically processed. Examples of CBHPs that are terminally sterilized include, but are not restricted to, cancellous bone, demineralized bone matrix, catgut sutures, biolo

Scope: This International Standard specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled ‘sterile’ and to CBHPs not labelled ‘sterile’. This International Standard is not applicable to: — procurement and transport of cell-based starting material used in processing of a CBHP, — cell banking, — control of genetic material, — control of non-microbial product contamination, — in vitro diagnostics (IVDs), or — natural medicines. EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids. This International Standard does not define biosafety containment requirements. This International Standard does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO 18362-2016 PDF

ISO 18362-2016 PDF

$13.00 $26.00